PREMIUM INSIGHT

Allscripts: Short More | $MDRX

Allscripts: Short More | $MDRX - mdrx

This is an institutional research note on Allscripts (MDRX) written by Hedgeye Healthcare analysts Tom Tobin and Andrew Freedman on August 5th. Shares of MDRX are down -14.5% since our Healthcare team wrote "Short More." But this short still has juice left. Continue reading to understand why Tobin and Freedman see an additional -35% downside from here.